What Researchers Did
Researchers prospectively enrolled 44 subacute traumatic brain injury patients and randomly assigned 22 to receive hyperbaric oxygen therapy (HBOT) and 22 to a control group to evaluate HBOT's effect on prognosis.
What They Found
The Glasgow Coma Scale (GCS) improved from 11.1 to 13.5 in the HBOT group, compared to 10.4 to 11.5 (p < 0.05) in the control group. Patients in the HBOT group also showed significant improvement in the Glasgow Outcome Scale (GOS) after 6 months.
What This Means for Canadian Patients
Hyperbaric oxygen therapy (HBOT) may offer a beneficial treatment option for Canadian patients recovering from subacute traumatic brain injury. This therapy could potentially improve neurological outcomes with minimal side effects.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study was limited by its relatively small sample size of 44 patients and a follow-up period of 3 to 6 months.